CYTOKINETICS INC — Director's Dealing 2023

Dec 19, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2023-12-18

Reporting Person: HENDERSON JOHN T (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-18	Common Stock	M	13020	$6.72	Acquired	44838	Direct
2023-12-18	Common Stock	S	2458	$36.34	Disposed	42380	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-18	Non-Qualified Stock Option (Right to Buy)	$6.72	M	13020	Disposed	2024-01-02	Common Stock (13020)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	83	Indirect

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023.

F2: Sell-to-cover transaction. Dr. Henderson acquired a net 10,562 shares of common stock, which he continues to hold.